Skip to main content

Advertisement

SpringerLink
Log in

Mutations of N-RAS, FLT3 and p53 genes are not involved in the development of acute leukemia transformed from myeloproliferative diseases with JAK2 mutation

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054–1061.

    Article  CAS  Google Scholar 

  2. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144–1148.

    Article  CAS  Google Scholar 

  3. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779–1790.

    Article  CAS  Google Scholar 

  4. Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 2005; 7: 387–397.

    Article  CAS  Google Scholar 

  5. Vainchenker W, Constantinescu SN . A unique activating mutation in JAK2 (V617F) is at the origin of polycythemia vera and allows a new classification of myeloproliferative diseases. Hematology (Am Soc Hematol Educ Program) 2005; 195–200.

  6. Nakano Y, Kiyoi H, Miyawaki S, Asou N, Ohno R, Saito H et al. Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene. Br J Haematol 1999; 104: 659–664.

    Article  CAS  Google Scholar 

  7. Levine RL, Loriaux M, Huntly BJ, Loh ML, Beran M, Stoffregen E et al. The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia. Blood 2005; 106: 3377–3379.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan

    M Suzuki, A Abe, M Murata, T Kinoshita & T Naoe

  2. Department of Infectious Diseases, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan

    H Kiyoi

  3. Department of Hematology, Yokkaichi Municipal Hospital, Mie, Japan

    Y Ito

  4. Department of Hematology and Oncology, JA Aichi Showa Hospital, Kohnan, Japan

    K Shimada & Y Morishita

Authors
  1. M Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H Kiyoi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Murata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K Shimada
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Y Morishita
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T Kinoshita
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. T Naoe
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suzuki, M., Abe, A., Kiyoi, H. et al. Mutations of N-RAS, FLT3 and p53 genes are not involved in the development of acute leukemia transformed from myeloproliferative diseases with JAK2 mutation. Leukemia 20, 1168–1169 (2006). https://doi.org/10.1038/sj.leu.2404186

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404186

  • Springer Nature Limited

This article is cited by

Search

Navigation